Rosalind, to support research into biology, drug discovery and translational medicine. The model is built to improve scientific workflows by helping researchers analyze literature, generate hypotheses ...

By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...

OpenAI says that it won’t bring the AI model powering deep research, its in-depth research tool, to its developer API while it figures out how to better assess the risks of AI convincing people to act ...

The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...

Posts from this topic will be added to your daily email digest and your homepage feed. Researchers found that o1 had a unique capacity to ‘scheme’ or ‘fake alignment.’ Researchers found that o1 had a ...

Google DeepMind today open-sourced AlphaGenome, an artificial intelligence model that researchers can use to study biological processes. The Alphabet Inc. unit first debuted the algorithm in June.

Khamosh Pathak is a freelance tech journalist with over 13 years of experience writing online. An accounting graduate, he turned his interest in writing and technology into a career. He holds a ...

OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a ...

Isa Fulford, a researcher at OpenAI, had a hunch that Deep Research would be a hit even before it was released. Fulford had helped build the artificial intelligence agent, which autonomously explores ...

Biogen isn’t shy about aspirations to expand beyond neurology and further establish itself in immunology and rare diseases. Recent business development deals have focused on enhancing the company’s ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...